What is it about?

The nature of Down Syndrome screening has changing substantially in recent years, especially following the introduction of non-invasive prenatal testing. Our study has demonstrated the risks and benefits of using different models of screening tests and the implications of each for the diagnosis of fetal anomalies.

Featured Image

Read the Original

This page is a summary of: Prenatal diagnostic testing and atypical chromosome abnormalities following combined first‐trimester screening: implications for contingent models of non‐invasive prenatal testing, Ultrasound in Obstetrics and Gynecology, April 2018, Wiley,
DOI: 10.1002/uog.18979.
You can read the full text:

Read

Contributors

Be the first to contribute to this page